pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,561
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
tigilanol tiglate
Angiosarcoma
Protein kinase C (PKC)
QBiotics Group Ltd
0
catalysts
Phase 2
timolol
Ocular Hypertension
Beta-1 adrenergic receptor
Beta-2 adrenergic receptor
Betaliq Inc
0
catalysts
Phase 2
tipelukast
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
MEDICINOVA INC
← prev
page 50 of 53
next →
131
Pain
89
Neurology
1
$MNOV
0
catalysts
Phase 2
tirapazamine
Colorectal Cancer
Teclison Ltd
0
catalysts
Phase 2
tisolagiline
tisolagiline [INN]
Dementia Associated With Alzheimer's Disease
$SCLX
Scilex Holding Co
0
catalysts
Phase 2
tivozanib
Wet (Neovascular / Exudative) Macular Degeneration
Platelet-derived growth factor receptor beta
Vascular endothelial growth factor receptor
Kyowa Kirin Co Ltd
0
catalysts
Phase 2
tolcapone
Tolcapone Oceanside (tolcapone)
Amyloidosis
Catechol O-methyltransferase
Corino Therapeutics Inc
0
catalysts
Phase 2
tolimidone
Type 2 Diabetes
Tyrosine-protein kinase Lyn
Melior Pharmaceuticals I Inc
0
catalysts
Phase 2
tominersen
Huntington Disease
Huntingtin mRNA
F. Hoffmann-La Roche Ltd
0
catalysts
Phase 2
tonabersat
Xiflam (tonabersat [INN])
Diabetic Nephropathy
Inflammx Therapeutics Inc
0
catalysts
Phase 2
topotecan
HYCAMTIN (topotecan [INN])
Retinoblastoma
Targeted Therapy Technologies LLC
0
catalysts
Phase 2
tosposertib
tosposertib [INN]
Solid Tumor
TiumBio Co Ltd
0
catalysts
Phase 2
toviblideg
Follicular Lymphoma
Bristol-Myers Squibb Co
0
catalysts
Phase 2
trabedersen
Oncomun (trabedersen [INN])
Metastatic Melanoma
Sapu Bioscience LLC
0
catalysts
Phase 2
trametinib dimethyl sulfoxide
Mekinist (trametinib dimethyl sulfoxide)
Malignant Glioma
Dual specificity mitogen-activated protein kinase kinase 2
Dual specificity mitogen-activated protein kinase kinase 1
$NVS
NOVARTIS AG
0
catalysts
Phase 2
traxivitug
Polyomavirus Infections
$VERA
Vera Therapeutics, Inc.
0
catalysts
Phase 2
trevotamig
trevotamig [INN]
Adenocarcinoma
$BCAB
BioAtla, Inc.
0
catalysts
Phase 2
trientine hydrochloride
Trientine Hydrochloride (trientine hydrochloride)
Congestive Heart Failure (Heart Failure)
Innolife Co Ltd
0
catalysts
Phase 2
trimetazidine
trimetazidine [INN]
Contrast Induced Nephropathy
Saghmos Therapeutics Inc
0
catalysts
Phase 2
troculeucel
troculeucel [INN]
Alzheimer's Disease
NKGen Biotech Inc
0
catalysts
Phase 2
trovostobart
trovostobart [INN]
Bladder Cancer
TuHURA Biosciences Inc
0
catalysts
Phase 2
tucidinostat
Metastatic Melanoma
HUYA Bioscience International LLC
0
catalysts
Phase 2
tulmimetostat
Endometrial Cancer
$NVS
NOVARTIS AG
0
catalysts
Phase 2
tuspetinib
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$APTOF
Aptose Biosciences Inc.
0
catalysts
Phase 2
tuvatexib
tuvatexib [INN]
Actinic (Solar) Keratosis
Vidac Pharma
0
catalysts
Phase 2
ulacamten
Diastolic Heart Failure (HFpEF)
$CYTK
CYTOKINETICS INC
0
catalysts
Phase 2
ulenistamab
ulenistamab [INN]
Metastatic Pancreatic Cancer
Prestige BioPharma Ltd
0
catalysts
Phase 2
umitrelimorgene autodencel
umitrelimorgene autodencel [INN]
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
0
catalysts
Phase 2
unasnemab
Traumatic Spinal Cord Injury
Repulsive guidance molecule A
Tanabe Pharma Corp
0
catalysts
Phase 2
urcosimod
Keratoconjunctivitis Sicca (Dry Eye)
$OKYO
OKYO Pharma Ltd
0
catalysts
